Pediatric Vitiligo

Nanette B. Silverberg

doi:10.1016/j.pcl.2013.11.008

Pediatric Vitiligo

Nanette B. Silverberg

Research output: Contribution to journal › Review article › peer-review

23 Scopus citations

Abstract

Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.

Original language	English
Pages (from-to)	347-366
Number of pages	20
Journal	Pediatric Clinics of North America
Volume	61
Issue number	2
DOIs	https://doi.org/10.1016/j.pcl.2013.11.008
State	Published - Apr 2014

Keywords

Autoimmunity
Corticosteroids
Depigmentation
Tacrolimus
Vitamin D
Vitiligo

Access to Document

10.1016/j.pcl.2013.11.008

Cite this

@article{2cffacf20a494460b869843b2c39ebb0,

title = "Pediatric Vitiligo",

abstract = "Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.",

keywords = "Autoimmunity, Corticosteroids, Depigmentation, Tacrolimus, Vitamin D, Vitiligo",

author = "Silverberg, {Nanette B.}",

year = "2014",

month = apr,

doi = "10.1016/j.pcl.2013.11.008",

language = "English",

volume = "61",

pages = "347--366",

journal = "Pediatric Clinics of North America",

issn = "0031-3955",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Pediatric Vitiligo

AU - Silverberg, Nanette B.

PY - 2014/4

Y1 - 2014/4

N2 - Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.

AB - Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.

KW - Autoimmunity

KW - Corticosteroids

KW - Depigmentation

KW - Tacrolimus

KW - Vitamin D

KW - Vitiligo

UR - http://www.scopus.com/inward/record.url?scp=84897620826&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2013.11.008

DO - 10.1016/j.pcl.2013.11.008

M3 - Review article

C2 - 24636650

AN - SCOPUS:84897620826

SN - 0031-3955

VL - 61

SP - 347

EP - 366

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

IS - 2

ER -

Pediatric Vitiligo

Abstract

Keywords

Access to Document

Fingerprint

Cite this